
Investors Target Beta Bionics Over Alleged Insulin Pump Failures
A class action lawsuit filed in San Diego alleges that Beta Bionics misled shareholders regarding the safety of its iLet Bionic Pancreas. The complaint claims the company concealed device malfunctions that caused dangerous insulin overdoses, triggering a sharp decline in BBNX stock value between July 2025 and February 2026.























